Country Overview (Pharma & Healthcare)


Publication Single User License (PDF) Price
Opportunity in the Indian Medical Information Market - 2015: Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Medical Information Market - 2015: Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Date Published: Apr 23 2015

Opportunity in the Indian Medical Information Market - 2015 report provides an insight into the Medical Information current market scenario, structure and practices.

In depth market scenario includes;
- Current market size estimates
- Market size by players – Top Companies
- Market size by product categories – Books, Journals and E-Medium
- Market size by end user segments – Hospitals and Others
- Market size by regions – North, South, East, West

$3,000.00
Denmark Pharmaceuticals and Healthcare Report Q2 2015

Denmark Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 22 2015
Denmark has a relatively small pharmaceutical market compared to many of its Western European counterparts. Despite the country's economy returning to growth in 2014, pharmaceutical sales are not expecting to follow suit until 2016.
 
$1,295.00
Mauritius Pharmaceuticals and Healthcare Report Q2 2015

Mauritius Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 22 2015
Although Mauritius has one of the smallest populations in the region, it has the highest per capita spending on pharmaceuticals, the sector of which is backed by encouraging governmental vision. With a high reliance on non-communicable and chronic disease therapies and an increasing elderly population, Mauritius will continue to remain an attractive destination for pharmaceutical investment.
 

Headline Expenditure Projections

$1,295.00
Namibia Pharmaceuticals and Healthcare Report Q2 2015

Namibia Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 22 2015
Recently updated storage requirements for pharmaceutical distributors demonstrate an improving regulatory environment in Namibia. The three main players Nampharm, Geka Pharma and Erongomed with sufficient recourses to meet the requirements should also be able to increase their market share either via acquisitions or as a result of smaller players going out of business. Namibia's pharmaceutical market is small but attractive, as demonstrated by an impressive presence of patented medicines.
 
$1,295.00
Portugal Pharmaceuticals and Healthcare Report Q2 2015

Portugal Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 22 2015
A modest rise in public and private healthcare expenditure in Portugal in 2015, as well as improving macroeconomic indicators both domestically and in key international trade partners, poses upside risk to Portugal's pharmaceuticals and healthcare sector growth forecasts over a multi-quarter horizon. However, given the government's emphasis on pharmaceuticals spending control, we expect the drug market negative growth to gradually moderate before entering positive territory by the end of our forecast period.
 
$1,295.00
United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2015

United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 22 2015
Further drug price reductions in the UAE will result in lower profit margins for drugmakers operating in the country, though we believe that an increasing volume of sales will offset losses from pharmaceutical companies and we have maintained our positive market forecast. Increased affordability levels among the population, compulsory health insurance and medical tourism are all key drivers of growth in the UAE pharmaceutical market.
 

Headline Expenditure Projections 

$1,295.00
Uzbekistan Pharmaceuticals and Healthcare Report Q2 2015

Uzbekistan Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 22 2015
$1,295.00
Vietnam Pharmaceuticals and Healthcare Report Q2 2015

Vietnam Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 22 2015
Vietnam's underdeveloped healthcare system will continue to be an impediment to pharmaceutical companies as patients face challenges in accessing drugs. This challenge is further compounded by the regional variations in healthcare infrastructure, including a concentration of doctors and hospital facilities in the urban provinces of the country.
 

Headline Expenditure Projections 

$1,295.00
Adult Diapers Market in the Americas 2015-2019

Adult Diapers Market in the Americas 2015-2019

Date Published: Apr 22 2015
Report forecast the Adult Diapers market in the Americas to grow at a CAGR of 5.31 percent over the period 2014-2019.
 
$3,000.00
New Zealand Medical Devices Report Q3 2015

New Zealand Medical Devices Report Q3 2015

Date Published: Apr 15 2015
The District Health Boards' focus on cost efficiency and a stronger policy on medical device reimbursement is likely affect the growth prospects of the New Zealand medical device market in 2015 and beyond. The strengthening of the US dollar has already affected import performance from the USA, the country's main supplier, and we expect this trend to continue in the medium term.
 

Headline Industry Forecasts 

$1,295.00
Russia Medical Devices Report Q3 2015

Russia Medical Devices Report Q3 2015

Date Published: Apr 15 2015
We expect the Russian medical device market to contract by a CAGR of 2.9% over the 2013-2018 period. The financial sanctions imposed by the West due to Russia's involvement in the Ukraine crisis, as well as the weakened currency and high inflation are expected to cause a deep recession in 2015, which will adversely affect medical device market growth, as less money is made available for healthcare. Import restrictions introduced in February 2015 may also reduce demand.
 

Headline Industry Forecasts 

$1,295.00
Singapore Medical Devices Report Q3 2015

Singapore Medical Devices Report Q3 2015

Date Published: Apr 15 2015
Rising healthcare costs have led to a revamp of the country's medical insurance scheme in 2015 making it compulsory for all. Demand for healthcare has also resulted in new healthcare development projects announced through to 2020. The large biomedical production industry continues to be a major sector in Singapore's total manufacturing output and the country continues to serve as a distribution hub for the region.
 

Headline Industry Forecasts 

$1,295.00
Ghana Pharmaceuticals and Healthcare Report Q2 2015

Ghana Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 15 2015
Our outlook for Ghana's pharmaceutical and healthcare market is becoming increasingly bearish. The National Health Insurance Scheme is facing backlash from both drugmakers and service providers due to a lack of payments. Furthermore, we believe that the scheme will come under even more scrutiny in light of the proposed government spending revision on the back of lower oil prices.
 

Headline Expenditure Projections

$1,295.00
Greece Pharmaceuticals and Healthcare Report Q2 2015

Greece Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 15 2015
Since the election of the Syriza party in early 2015, Greece has seen considerable escalation in both political and economic uncertainty. This will limit the implementation of reform in the health sector and exacerbate the already high operational risks borne by drugmakers.
 
$1,295.00
Iraq Pharmaceuticals and Healthcare Report Q2 2015

Iraq Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 15 2015
Iraq's attractiveness as a pharmaceutical market is highly dependent on the security situation in the country. With the Islamic State (IS) negatively impacting healthcare access in the northern states, Iraq's pharmaceutical market appeal to foreign investors has weakened. With IS expected to remain resilient in the north in the short term, we highlight Iraq offers a difficult operating environment for drugmakers.
 

Headline Expenditure Projections 

$1,295.00
Adult Diaper Market in the APAC 2015-2019

Adult Diaper Market in the APAC 2015-2019

Date Published: Apr 15 2015
Report forecast the Adult Diapers market in the APAC region to grow at a CAGR of 14.30 percent over the period 2014-2019.
 
$2,500.00
Italy Pharmaceuticals and Healthcare Report Q2 2015

Italy Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 15 2015
SNS pharmaceutical expenditure will decline in 2015 - creating revenue pressures for drugmakers and pharmacies in Italy and increasing out-of-pocket costs for the population. In February 2015, it was announced that the public healthcare costs will be slashed by EUR2.6bn (USD2.9bn) in 2015. We note that this accounts for a large proportion of the EUR5.2bn (USD5.8bn) spending cuts announced by the government.
 

Headline Expenditure Projections 

$1,295.00
Norway Pharmaceuticals and Healthcare Report Q2 2015

Norway Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 15 2015
Norway's epidemiological profile will continue to be attractive to manufacturers of medicines for non-communicable diseases. Despite the relative rapid uptake of innovative pharmaceuticals, the burden of chronic conditions will only decrease slightly over the next 15 years. Like many other developed states, Norway is introducing cost-containment measures that will restrict the commercial opportunities presented to drugmakers.
 

Headline Expenditure Projections

$1,295.00
Serbia Pharmaceuticals and Healthcare Report Q2 2015

Serbia Pharmaceuticals and Healthcare Report Q2 2015

Date Published: Apr 15 2015
A demand for austerity measures and public sector cuts by the IMF and the ongoing privatisation of state-owned enterprises will push the Serbian government to reduce its fiscal expenditure. The national health insurance fund will be pressured into reining in its costs, and we expect it will use its purchasing power to extract discounts from pharmaceutical manufacturers. The outlook for the Serbian pharmaceutical market in 2015 is expected to worsen.
 

Headline Expenditure Projections

$1,295.00
Asia-Pacific Markets for Dental Bone Graft Substitutes and Barrier Membranes

Asia-Pacific Markets for Dental Bone Graft Substitutes and Barrier Membranes

Date Published: Apr 14 2015
The loss of bone can cause discomfort and prevent patients from receiving dental implants. Bone grafting procedures using bone graft substitutes (BGS) are performed to repair bone loss. Bone grafting can be performed during periodontal procedures in an attempt to save a tooth, or during a dental implant procedure to replace a tooth. Tissue engineering products and dental membranes can be used in conjunction with BGS to increase the rate and extent of bone regeneration.
 
$7,995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data